Ledger.Open graph →
SEC Form D · Amendment · filed October 16, 2018

AZTherapies, INC

Offering
$25.5M
Sold
$16.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Peter S. Conti · Boston, MADirectorJohn S. Porter · Boston, MADirectorDavid R. Elmaleh · Boston, MAExec · DirectorDavid S. Taft · Boston, MADirectorRobert S. Warren · Boston, MAExecRonald S. Tompkins · Boston, MADirectorKeith S. Greenfield · Boston, MAExec · DirectorGillian S. Sandler · Boston, MADirectorSergei Nodelman · New York, NYExec · DirectorDavid H. Chung · St. Louis Park, MNDirectorAndrew K. Elbardissi · St. Louis Park, MNDirectorStephen Quin · Vancouver, British Columbia, CanadaExecRon A. Nelson · St. Louis Park, MNDirectorIvana B. Faltysova · Grand Cayman, Cayman IslandsExec · DirectorCary B. Marr · Grand Cayman, Cayman IslandsDirectorJason Chapman · Denver, CODirectorKaren S. Reeves · Boston, MAExecDon Guthrie · Seattle, WAExec · DirectorA. Daniel Greenshield · Seattle, WAExecWilliam Bennett · Vancouver, British Columbia, CanadaDirectorGeoff Entress · Seattle, WAExec · DirectorSean Glass · Arlington, VADirectorRichard Foster · Arlington, VADirectorGurinder Ahluwalia · SAN FRANCISCO, CADirectorCameron Golden · Atlanta, GADirectorKaren S. Reeves · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗